ArticleSensors and actuators reports2025
Bipolar electrochemically generated fluorescence detector for microchip electrophoresis with and without a potentiostat: Application to reducible analyte detection.
Article in Sensors and actuators reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Bright and Dark Sides of Nitric Oxide in Neurodegenerative Diseases.Journal of personalized medicine · 2026Review
- Electrokinetic Microfluidics at the Convergence Frontier: From Charge-Driven Transport to Intelligent Chemical Systems.Micromachines · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Microchip electrophoresis (ME) is a separation method that makes it possible to quickly analyze multiple species in small volume samples in a miniaturized format. Two commonly employed detection approaches for ME are electrochemistry and fluorescence. Electrochemical detection can be employed for direct detection of analytes via redox chemistry, while fluorescence generally offers lower limits of detection but often requires analyte derivatization. The present study uses bipolar electrochemistry to couple the two detection methods into a single device as a detector for that encompasses the advantages of both techniques. This system employs a closed bipolar electrode (BPE) that converts the cathodic amperometric current produced at the separation (sensing) pole to a fluorescence response generated at the reporting pole. Two model analytes, benzoquinone and resazurin, were separated and detected using ME with reductive amperometric detection at the sensing pole of the BPE. A potentiostat was used to control the bipolar electrode. The response was then converted to fluorescence through the oxidation of 2,7-dichlorodihydrofluorescein in the reporting channel. This system was subsequently modified to run without a potentiostat by using the separation voltage to bias the BPE sensing pole. A voltage applied across the reporting channel was used to generate electroosmotic flow as well as bias the corresponding pole of the BPE. This potentiostat-free mode was evaluated for the determination of 3-nitro-l-tyrosine, a reducible biomarker of oxidative stress. Lastly, a sacrificial electrochemically active species, Trolox
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.